---
document_datetime: 2023-09-21 17:04:14
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/steps-after-cutoff/trazec-epar-steps-taken-after-authorisation-when-cutoff-date-has-been-used_en.pdf
document_name: trazec-epar-steps-taken-after-authorisation-when-cutoff-date-has-been-used_en.pdf
version: success
processing_time: 1.0825302
conversion_datetime: 2025-12-30 08:59:35.630653
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Procedural steps taken after granting the Marketing Authorisation

For procedures finalised after 1 February 2004 please refer to module 8B.

Subsequent post Marketing Authorisation applications agreed upon are summarised in the table below:

| Scope                                                                                                                                                                                                                                                                                                                                                                                                                                                               | Application number   | Type of modification 1   | Notification/ Opinion issued on 2   | Commission Decision Issued/amended on   |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------|--------------------------|-------------------------------------|-----------------------------------------|
| Replacement of an excipient with a comparable excipient                                                                                                                                                                                                                                                                                                                                                                                                             | I/0001               | I                        | 08.06.01                            | -                                       |
| Addition of a manufacturing site for Trazec film-coated tablets and change of batch release site                                                                                                                                                                                                                                                                                                                                                                    | I/0002               | I                        | 12.06.02                            | 11.07.02                                |
| Change in manufacturing batch size of finished product                                                                                                                                                                                                                                                                                                                                                                                                              | I/0003               | I                        | 12.06.02                            | -                                       |
| Addition of alternative packaging site                                                                                                                                                                                                                                                                                                                                                                                                                              | I/0004               | I                        | 24.05.02                            | -                                       |
| Addition of alternative packaging site                                                                                                                                                                                                                                                                                                                                                                                                                              | I/0005               | I                        | 24.05.02                            | -                                       |
| Extension of product shelf-life                                                                                                                                                                                                                                                                                                                                                                                                                                     | I/0006               | I                        | 17.07.02                            | 30.08.02                                |
| Change to the finished product specification                                                                                                                                                                                                                                                                                                                                                                                                                        | I/0007               | I                        | 09.10.02                            | -                                       |
| Update of the Summary of Product Characteristics (SPC) to include new information regarding the interaction between nateglinide and sulfinpyrazone and to include information on the co-administration of nateglinide and gemfibrozil. The Package Leaflet has been updated accordingly. The paragraph on hepato-biliary disorders in section 4.8 of the SPC has been updated. In addition minor changes and an update of the local representatives have been done. | II/0008              | II                       | 25.09.03                            | 14.01.04                                |

<!-- image -->

T refers to a transfer of a Marketing Authorisation in accordance with Commission Regulation (EC) No 2141/96 of 7 November 1996.

Medicinal product no longer authorised Scope Replacement of an excipient with a comparable excipient Addition of  a manufacturing site for Trazec film-coated tablets and change of batch release site Change in manufacturing batch size of finished product Addition of alternative packaging site Addition of alternative packaging site Extension of product shelf-life Change to the finished product specification Update of the Summary of Product Characteristics (SPC) to include new information regarding the interaction between nateglinide and sulfinpyrazone and to include information on the co-administration of nateglinide and gemfibrozil. The Package Leaflet has been updated accordingly. The paragraph on hepato-biliary disorders in section 4.8 of the SPC has been updated. In addition minor changes and an update of the local representatives have been done. 1 For variations before 1 October 2003 in accordance with Commission Regulation (EC) No. 542/95 of 10 March 1995, as amendedand and for variations after 1 October 2003 in accordance with Commission Regulation (EC) No. 1085/2003: I refers to a minor variation (Type I variation); II refers to a major variation (Type II variation); I/II refers to a minor variation following the procedure set out in Article 6, 7 and 8 of the Regulation; X refers to an Annex II application.

N refers to a notification in accordance with Article 61(3) of Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001.

2 For Notifications and Type I variations, the date of entry into force of the change is the EMEA Notification date. The Commission Decision will be amended accordingly.